A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine

NCT06607380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetanus

Interventions

BIOLOGICAL: TNM002
BIOLOGICAL: Adsorbed tetanus vaccine
BIOLOGICAL: TNM002 + adsorbed tetanus vaccine

Sponsor

Zhuhai Trinomab Pharmaceutical Co., Ltd.